APWA
GSK icon

Atlas Private Wealth Advisors’s GSK GSK Stock Holding History

Atlas Private Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-107
Closed -$5K – 371
2021
Q3 		$5K Sell
107
-71
-40% -$3.57K ﹤0.01% 566
2021
Q2 		$9K Buy
178
+71
+66% +$3.41K ﹤0.01% 483
2021
Q1 		$5K Hold
107
– – ﹤0.01% 610
2020
Q4 		$5K Hold
107
– – ﹤0.01% 522
2020
Q3 		$5K Hold
107
– – ﹤0.01% 475
2020
Q2 		$5K Buy
+107
New +$5.49K ﹤0.01% 500

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Atlas Private Wealth Advisors's GSK Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of GSK (GSK) in Q4 2021, closing a stake of 107 shares — an estimated $5K sold.

Atlas Private Wealth Advisors first reported a position in GSK in Q2 2020 and held it in 6 quarters. The position peaked at $9K in Q2 2021. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Atlas Private Wealth Advisors reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 107 GSK shares in Q4 2021, an estimated $5K.
  • Atlas Private Wealth Advisors first reported a position in GSK in Q2 2020 and held it in 6 quarters.
  • Atlas Private Wealth Advisors's GSK position peaked at $9K in Q2 2021.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.